Inter Parfums (IPAR) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
5 Nov, 2026Executive summary
Q3 net sales were flat at $429.5M; operating income rose to $117.9M from $108.6M, and net income attributable to common shareholders reached $68.2M versus $65.8M.
Nine-month sales increased 1% to $1,115.4M; attributable net income rose to $142.1M from $140.3M, and diluted EPS reached $4.43 versus $4.36.
FY2026 sales guidance increased from €1.48B to ~€1.49B; diluted EPS guidance remained $4.85.
Financial highlights
Q3 gross profit was $288.2M versus $272.8M; nine-month gross profit was $736.4M versus $709.9M.
Q3 net income attributable to common shareholders rose 4% to $68.2M; diluted EPS was $2.13 versus $2.05.
Nine-month operating income was $240.9M versus $242.8M; attributable net income was $142.1M versus $140.3M.
Q3 SG&A was $170.3M versus $164.3M; nine-month SG&A was $495.4M versus $467.1M, reflecting higher employee, royalty, logistics and marketing costs.
Outlook and guidance
FY2026 sales guidance rose from €1.48B to ~€1.49B; diluted EPS guidance remained $4.85, including tariff-refund benefits.
Delayed gift-set shipments shifted ~$10M of U.S.-based sales into Q4; excluding this timing impact, Q3 U.S. sales would have been flat and nine-month growth 6%.
Full-year advertising and promotional spending is expected to approach ~21% of sales as tariff refunds are reinvested in marketing and brand support.
Management cited major launches, brand additions and productivity initiatives as supports for a measured, positive outlook for 2027 and 2028; initial FY2027 guidance was scheduled for November 18, 2026.
Latest events from Inter Parfums
- Voting standards for Proposal 3 and other matters clarified; majority approval required.IPAR
Proxy filing - Sustained growth, strong brand launches, and robust shareholder returns define recent performance.IPAR
Investor presentation - Key votes on directors, executive pay, and stock plan extension are set, with board support.IPAR
Proxy filing - Net sales grew 2% to $685.9M, with strong U.S. and key brand growth and major launches ahead.IPAR
Q2 2026 - Q1 2026 net sales up 2% to $345M, gross margin 65.1%, net income $43.4M, guidance reaffirmed.IPAR
Q1 2026 - Record sales and EPS in FY2025, with strong brand growth and steady 2026 outlook.IPAR
Q4 2025 - Record Q3 sales and earnings, with 2024 guidance reaffirmed and strong holiday outlook.IPAR
Q3 2024 - Record Q2 sales and margin gains, strong new launches, and 2024 guidance reaffirmed.IPAR
Q2 2024 - Record sales, robust innovation, and 4% growth outlook with higher dividend for 2025.IPAR
Q4 2024